Chimerix appoints M. Michelle Berrey, M.D., M.P.H. as CEO Chimerix announced the appointment of M. Michelle Berrey, M.D., M.P.H. to the position of President and CEO. Dr. Berrey succeeds Kenneth I. Moch following his resignation from that role to pursue other interests. In addition, Dr. Berrey will continue to serve as Chimerix's Chief Medical Officer.
UBS to hold a conference Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 19 at 8 am; not all company presentations may be webcasted. Webcast Link